Indian pharmaceutical exports to the US generate billions in revenue — yet many companies suffer from shrinking profit margins due to poor tax planning and tariff exposure. With profit margins already razor-thin in generics and regulatory complexities in the US market, weak tax strategy can turn profitable exports into margin killers. Learn how strategic tax planning can unlock saving... https://indamadvisors.com/how-lack-of-us-tax-planning-reduces-profit-margins-for-indian-pharmaceutical/